Seeking Alpha
  • The Scientist
    CYTK Omecamtiv program has ridiculous potential. Currently NO good drugs for HF (big problems with SE's). IV HF drugs expensive $1k+/day
    5/21/12
    Reply (2)
    • The Scientist: Market potential in US: 5M pts x $1K/day = very large potential. This is IF drug passes trials.
      5/21/12
    • iadops40: Sci, I have been eyeing CYTK, impressive pipeline. I'm a little concerned w/ such a small market cap. Whats their finance look like?
      5/21/12